Literature DB >> 20100955

Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.

Frances A Shepherd, Ming-Sound Tsao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100955     DOI: 10.1200/JCO.2009.26.3996

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Primary endpoints in cancer trials.

Authors:  Kurt Ulm
Journal:  J Thorac Dis       Date:  2011-06       Impact factor: 2.895

2.  Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer.

Authors:  Hongying Lv; Ting Han; Xiaoli Shi; Yasai Yao; Yongru Yao; Wensheng Qiu; Lu Yue; Jun Liang
Journal:  Med Oncol       Date:  2014-06-24       Impact factor: 3.064

3.  Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.

Authors:  A Gualberto; M L Hixon; D D Karp; D Li; S Green; M Dolled-Filhart; L G Paz-Ares; S Novello; J Blakely; C J Langer; M N Pollak
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

4.  Accuracy of Cytology Specimen and Needle Core Biopsies for Detection of KRAS Mutation in Non-Small Cell Carcinoma: Comparison With Resection Specimen.

Authors:  Ismatun Swati; Shengle Zhang; Jamie Tull; Kamal K Khurana
Journal:  World J Oncol       Date:  2011-12-19

5.  Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer.

Authors:  Ying-Qiang Lu; Kai-Hua Lu
Journal:  Chronic Dis Transl Med       Date:  2017-03-11

Review 6.  Personalized targeted therapy for lung cancer.

Authors:  Kehua Wu; Larry House; Wanqing Liu; William C S Cho
Journal:  Int J Mol Sci       Date:  2012-09-13       Impact factor: 6.208

7.  An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC).

Authors:  Cindy Quinton; Peter M Ellis
Journal:  Cancers (Basel)       Date:  2011-09-13       Impact factor: 6.639

Review 8.  [Personalized targeted therapy for lung cancer].

Authors:  Kehua Wu; Larry House; Wanqing Liu; William C S Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.